These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 33557763

  • 1. Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study.
    Pan CH, Chien SC, Chen CJ, Shih CM, Hsieh MH, Huang CY, Bi WF, Chan CS, Kao YT, Hsiao CY, Chiang SJ, Chiang KH, Huang JH, Liu YR, Luo JD, Huang HY, Wu CH.
    BMC Cardiovasc Disord; 2021 Feb 08; 21(1):77. PubMed ID: 33557763
    [Abstract] [Full Text] [Related]

  • 2. Differentially expressed miR-152, a potential biomarker for in-stent restenosis (ISR) in peripheral blood mononuclear cells (PBMCs) of coronary artery disease (CAD) patients.
    Maheronnaghsh M, Niktab I, Enayati S, Amoli MM, Hosseini SK, Tavakkoly-Bazzaz J.
    Nutr Metab Cardiovasc Dis; 2021 Apr 09; 31(4):1137-1147. PubMed ID: 33712363
    [Abstract] [Full Text] [Related]

  • 3. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention.
    Dai R, Liu Y, Zhou Y, Xiong X, Zhou W, Li W, Zhou W, Chen M.
    J Clin Lab Anal; 2020 Jan 09; 34(1):e23013. PubMed ID: 31495986
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.
    Yuan L, Dong J, Zhu G, Bao J, Lu Q, Zhou J, Jing Z.
    Sci Rep; 2019 Feb 04; 9(1):1402. PubMed ID: 30718561
    [Abstract] [Full Text] [Related]

  • 5. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
    Baktashian M, Saffar Soflaei S, Kosari N, Salehi M, Khosravi A, Ahmadinejad M, Moohebati M, Ebrahimi M, Rahmani F, Khameneh-Bagheri R, Ahmadi M, Sadabadi F, Tayefi M, Bazhdanzadeh S, Ferns GA, Hashemi SM, Pasdar A, Ghayour-Mobarhan M.
    Cardiovasc Revasc Med; 2019 Jul 04; 20(7):583-587. PubMed ID: 30232022
    [Abstract] [Full Text] [Related]

  • 6. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
    He M, Gong Y, Shi J, Pan Z, Zou H, Sun D, Tu X, Tan X, Li J, Li W, Liu B, Xue J, Sheng L, Xiu C, Yang N, Xue H, Ding X, Yu C, Li Y.
    PLoS One; 2014 Jul 04; 9(11):e112043. PubMed ID: 25427155
    [Abstract] [Full Text] [Related]

  • 7. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
    Tesche C, De Cecco CN, Vliegenthart R, Duguay TM, Stubenrauch AC, Rosenberg RD, Varga-Szemes A, Bayer RR, Yang J, Ebersberger U, Baquet M, Jochheim D, Hoffmann E, Steinberg DH, Chiaramida SA, Schoepf UJ.
    J Cardiovasc Comput Tomogr; 2016 Jul 04; 10(5):377-83. PubMed ID: 27431607
    [Abstract] [Full Text] [Related]

  • 8. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May 04; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 9. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
    Song T, Fu Y, Wang Y, Li W, Zhao J, Wang X, Wang H, Zhao Y, Fu X.
    BMC Cardiovasc Disord; 2021 Jan 07; 21(1):24. PubMed ID: 33413149
    [Abstract] [Full Text] [Related]

  • 10. Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis.
    Saavedra N, Rojas G, Herrera J, Rebolledo C, Ruedlinger J, Bustos L, Bobadilla B, Pérez L, Saavedra K, Zambrano T, Lanas F, Salazar LA.
    Biomed Res Int; 2020 Jan 07; 2020():2509039. PubMed ID: 33015157
    [Abstract] [Full Text] [Related]

  • 11. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP, Xu WT, Wang L, Li H, Shao CL, Gu HB, Chan SP, Xu HF, Yang XJ.
    Coron Artery Dis; 2015 Jan 07; 26(1):5-10. PubMed ID: 25211654
    [Abstract] [Full Text] [Related]

  • 12. Circulating microRNA-21 as Stable Blood-Based Markers for Patients With ISR After PCI.
    Zhang X, Xiao XP, Ren XA, Xue W.
    Heart Surg Forum; 2020 Oct 14; 23(6):E756-E762. PubMed ID: 33234202
    [Abstract] [Full Text] [Related]

  • 13. Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction.
    Wang Y, Chang W, Zhang Y, Zhang L, Ding H, Qi H, Xue S, Yu H, Hu L, Liu D, Zhu W, Wang Y, Li P.
    J Cell Physiol; 2019 Apr 14; 234(4):4778-4786. PubMed ID: 30256407
    [Abstract] [Full Text] [Related]

  • 14. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R, Yang Q, Xi R, Li L, Shi D, Chen K.
    BMC Cardiovasc Disord; 2017 Aug 22; 17(1):227. PubMed ID: 28830367
    [Abstract] [Full Text] [Related]

  • 15. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
    Wang P, Qiao H, Wang R, Hou R, Guo J.
    BMC Cardiovasc Disord; 2020 Dec 04; 20(1):510. PubMed ID: 33276720
    [Abstract] [Full Text] [Related]

  • 16. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
    He YH, Wang XQ, Zhang J, Liu ZH, Pan WQ, Shen Y, Zhu ZB, Wang LJ, Yan XX, Yang K, Zhang RY, Shen WF, Ding FH, Lu L.
    Arterioscler Thromb Vasc Biol; 2017 Apr 04; 37(4):717-729. PubMed ID: 28183701
    [Abstract] [Full Text] [Related]

  • 17. Visit-to-visit HbA1c variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention.
    Yang CD, Shen Y, Lu L, Yang ZK, Hu J, Zhang RY, Shen WF, Ding FH, Wang XQ.
    Cardiovasc Diabetol; 2020 Sep 04; 19(1):133. PubMed ID: 32887588
    [Abstract] [Full Text] [Related]

  • 18. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population　- Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
    Wang X, Dong Y, Fang T, Wang X, Chen L, Zheng C, Kang Y, Jiang L, You X, Gai S, Wang Z, Cao H.
    Circ J; 2020 Jun 25; 84(7):1155-1162. PubMed ID: 32404537
    [Abstract] [Full Text] [Related]

  • 19. [Effects of miRNA-1,miRNA-21 in plasma on in-stent restenosis in patients with coronary heart disease and diabetes mellitus after percutaneous coronary intervention].
    Guan JJ, Zhang Y, Liu YJ.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Apr 08; 34(4):304-308 384. PubMed ID: 30788936
    [Abstract] [Full Text] [Related]

  • 20. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A, Tekiner F, Karakurt A, Sirin G, Duman D.
    Coron Artery Dis; 2014 Sep 08; 25(6):469-73. PubMed ID: 24614629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.